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Summary 
The  murine  heat-stable  antigen  (HSA)  is  a  glycosyl-phosphatidylinositol-linked  cell  surface 
protein which has been implicated in cellular adhesion processes, the co-stimulation  of CD4 + 
T  cells,  and B  cell memory. We have recently  demonstrated  a  significant reduction  in pro-B 
and pre-B lymphocytes in transgenic  mice that overexpress HSA.  We now report that cross- 
linking  HSA with  the  M1/69  monoclonal  antibody  induces  the  apoptosis  of cultured  B  cell 
precursors  in  a  stomal  cell  and  cytokine-independent  manner  and  that  sensitivity  to  HSA- 
mediated cell death increases with developmental maturity. The cross-linking of HSA does not 
induce apoptosis in mature splenic B  cells, but instead inhibits their ability to proliferate in re- 
sponse  to anti-CD40  +  IL-4. Taken together,  these  data implicate  HSA as a potent  negative 
regulator of B  cell development and activation. 
T 
he murine heat-stable antigen (HSA) 1 is a glycosyl-phos- 
phatidylinositol (GPI)-linked protein (1) which has cap- 
tured  the  interest  of many laboratories  for  over a  decade 
due  to  its  unusual  structure,  its  fluctuating  pattern  of ex- 
pression  on  many  hematopoietic  lineages  and  its  role  in 
cellular adhesion,  the co-stimulation ofT  lymphocytes and 
B  cell memory. The molecular cloning (2) and biochemical 
analysis (2, 3)  of HSA has revealed that it is composed of a 
27-amino  acid  polypeptide  core  which  contains  several 
potential  N-  and  O-linked  glycosylation  target sites.  HSA 
displays  considerable  size  heterogeneity  among  the  he- 
matopoietic  lineages  (35-70  kD)  (2,  3)  leading  many  to 
speculate  that  HSA  is  glycosylated  in  a  cell  type-specific 
manner (2, 3). 
The  expression  of  HSA  is  regulated  during  B  lym- 
phopoiesis.  It is not detected on the earliest phenotypically 
defined pro-B cell found within the B2201°Thy-1 l° and Frac- 
tion A  (B220+CD43+HSA-BP-1 -)  subpopulations,  how- 
ever, it is subsequently upregulated  on B220+CD43 + lym- 
phocytes  undergoing  D-J  and  V-DJ  rearrangements  and 
reaches  its  highest  level  of expression  on  large,  cycling, 
IL-7-responsive  pro-B  cells  (4).  High  levels  of HSA  ex- 
pression  are  also  found  on  pre-B  and  immature  B  cells 
1Abbreviations used in this  paper: cy-5, cyanine succinimidylester; FCS, fetal 
calf serum; HBSS, Hank's Balanced Salt Solution; HSA, heat-stable anti- 
gen; IMDM, Iscove's modified Dulbecco's media; PI, propidium iodide. 
within the bone marrow (4, 5) and on newly emerged B cells 
in the spleen  (5), but further maturation is accompanied by 
the downregulation  of HSA (5-7). Interestingly, low to ab- 
sent HSA expression is thus far the only phenotypic marker 
which  distinguishes  populations  enriched for memory ver- 
sus primary B  cell precursors (6-8). 
The precise functional  role of HSA remains unresolved. 
On mature peripheral B  lymphocytes, HSA acts synergisti- 
cally with B7 to co-stimulate CD4 + T  cells (9). In the bone 
marrow, the regulated expression of liSA is critical for nor- 
mal  B  lymphopoiesis,  since  transgenic  mice  that  overex- 
press  HSA  within  the  B220+Thy-11°  and  B220+CD43 + 
subpopulations  display a two-fold depletion in the absolute 
number of cells from these compartments and a 20-fold re- 
duction in the frequency of IL-7 responsive clonogenic pro- 
genitors  (10).  The defect in B  lymphopoiesis was found to 
be inversely related to the level of HSA overexpression and 
intrinsic  to  the  B  cell  compartment,  since  the  phenotype 
was reproducible in BALB/c-nu/nu  and SCID mice. 
Several models could provide a mechanistic basis for the 
B  cell phenotype found in these mice. HSA may be an ad- 
hesion  molecule  which  is  necessary  for  the  homing  and 
stabilization of B  cell precursors to the bone marrow micro- 
environment,  and  thus  its overexpression may inappropri- 
ately retain B  cell  precursors  on  the  bone  marrow stroma 
and impede further maturation.  This model is supported by 
the findings  that HSA may be a ligand for P-selectin  (11). 
In addition,  the  HSA-specific monoclonal  antibody 79  in- 
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ternatively, HSA may modify the specificity and/or avidity 
of other adhesion molecules known to be important for B 
cell differentiation. Indeed, B  cell precursors derived from 
HSA knockout mice display altered VLA-4-VCAM-1  and 
negligible VLA-4-fibronectin interactions in vitro (13).  The 
observed depletion  of B  cells in  mice  which  overexpress 
HSA could also be due to signals transduced either directly 
or indirectly via HSA which inhibit the expansion and/or 
survival of early B  cell precursors. This model is supported 
by the  ability of an  HSA-specific monoclonal antibody to 
inhibit the anti-CD3-driven proliferative response of CD4 + 
T  cells (14)  and to induce Ca  2+  fluxes in activated B  lym- 
phoblasts (12) and on neuronal cells when complexed with 
L1  (15).  The  modulation  of HSA  might  control  the  re- 
sponsiveness  of B  cell precursors  to  stromal  cell elements 
and cytokines, such as IL-7. This latter model is supported 
by the finding that the most profoundly affected cell popu- 
lation in the HSA transgenic mice are IL-7-responsive clo- 
nogenic progenitors. 
To more directly evaluate the role of HSA in B  cell de- 
velopment and to  distinguish among the potential models 
which address its function,  we have  assessed the  effects of 
the HSA-specific M1/69 monoclonal antibody on cultured 
bone marrow progenitors representative of various stages of 
B  cell development and on mature resting B  lymphocytes. 
We  demonstrate  that  the  cross-linking  of HSA  induces 
apoptotic cell death in early B  cell precursors in a manner 
which is independent of the presence of stromal cells and/or 
cytokines.  We  further  show  that  IL-7-responsive  clono- 
genic  progenitors  and  their  progeny  display  the  greatest 
sensitivity to  induction  of programmed  cell death  by the 
antibody despite not having any significant increase in cell 
surface HSA expression relative to their less mature  coun- 
terparts. Finally, the modulation of HSA with M1/69  also 
inhibits the proliferative response of mature resting B  lym- 
phocytes  to  anti-CD40  +  IL-4.  These  data  suggest  that 
HSA can negatively regulate early B  cell differentiation by 
serving as  an  initiator of programmed  cell death  and  can 
suppress  B  cell  activation  by  inhibiting  the  anti-CD40- 
induced proliferative response of mature resting B  cells. 
Materials  and Methods 
Mice.  6-8-wk-old  (C57BL/6J  ×  C3H)F  1 mice  were  bred 
and maintained in microisolators under pathogen-free conditions 
in the animal facility of the British Columbia Cancer Research 
Centre. 
Antibodies  Used in  Proliferation Assays  and  B  Cell  Cultures. 
M1/69.16.11HL  (rat  IgG2b  anti-mouse  HSA),  RG7/11.1 
(mouse IgG2b anti-rat IgG2b Fc), FD441.8 (rat IgG2b anti-mouse 
LFA-1 c¢ chain), R1-2 (rat IgG2b anti-mouse VLA-4 integrin re- 
ceptor) Jlld.2,  and  YE1/48.10  (16)  (rat IgG2b  anti-Ly-49A) 
hybridomas  were  obtained  from  the  American  Type  Culture 
Collection (Rockvifle, MD).  The antibodies were purified from 
hybridoma  culture  supernatants  on  protein  G  affinity columns 
and according to standard procedures (17).  Purified 20C9  (ham- 
ster anti-mouse HSA) was generously provided by Dr. Yang Liu 
(New York University Medical Centre).  The  IC10 hybridoma 
(rat  IgG2a anti-mouse  CD40)  was  graciously provided by Dr. 
Maureen Howard (DNAX, La Jolla, CA). 
Flow Cytometry.  M1.69.16.11HL  was  labeled  with  biotin- 
succinimidylester (Pierce Chem.  Co., Rockford, IL), fluorescein 
isothiocyanate (FITC) (Sigma Chem. Co., St. Louis, MO), or cy- 
anine 5-succinimidylester (cy-5) (FluoroLink, Pittsburgh, PA) by 
standard procedures (17).  FITC- and phycoerythrin (PE)-labeled 
anti-B220, FITC- and biotinylated anti-CD43  ($7) and biotiny- 
lated anti-c-kit  were  purchased from  PharMingen  (San  Diego, 
CA). FITC-labeled Thyl.2 was purchased from Boehringer Mann- 
heim Biochemicals (Indianapolis, IN). FITC-labeled anti-mouse 
IgM and PE-labeled anti-mouse IgD were obtained from South- 
ern  Biotechnology  Associates  (Birmingham,  AL).  R-PE-  and 
FITC-conjugated streptavidin were purchased from Jackson Im- 
munoResearch Laboratories (Westgrove, PA). 
To phenotypically analyze B cell precursor populations, single 
cell suspensions of 1 X 106 cells were stained on ice for 30 min in 
100 bd of Hanks' Balanced Salt Solution (HBSS)  (StemCell Tech- 
nologies, Vancouver, BC) supplemented with 5% fetal bovine calf 
serum (FCS). Cells were washed twice with HBSS containing 5% 
FCS and resuspended in the same buffer containing 1 Ixg/ml pro- 
pidium iodide (PI). Flow cytometric analysis was performed using 
either a FACSort  ®, FACScan  ®, or FACStar  pLUs® flow cytometer 
equipped with  PC  LYSIS  II  ® software  (Hewlett  Packard  Co., 
Palo Alto, CA). 
Cell Culture and Hemopoietic Assays 
Pro-B Cell Assays.  Pro-B lymphocyte cultures were initiated 
as described by Faust et al.  (18).  The  $17  stromal cell line was 
maintained  in  RPMI  1640  supplemented  with  5%  FCS  (no. 
6350,  lot 906;  StemCell Technologies), 50 IXM 2-rnercaptoetha- 
nol, 10 mM sodium bicarbonate, 10 mM Hepes, 100 U/ml peni- 
cillin, 100  Ixg/ml streptomycin, and 2 mM glutamine (complete 
RPMI)  (all cell culture reagents used in this study unless other- 
wise  specified are  from  StemCell  Technologies).  Stromal  cells 
were plated into 6-well plates (Falcon 3046;  Becton Dickinson 
and Co., Lincoln Park, NJ) at a density of 1 X 105 cells per 6-cm  2 
well and expanded to  80%  confluency. Bone  marrow  was  ob- 
tained by flushing the femurs of 6-8-wk-old mice with complete 
RPMI using a 22-gauge needle and 2 X 10  s bone marrow cells/ml 
were  plated  onto  pre-established stromal  cell  layers.  Cultures 
were fed biweekly. These and all other lymphoid and myeloid 
cultures described below were maintained in a humidified incu- 
bator at 37°C and 5% CO2. Cells were removed from the stroma 
as previously described (18). The cell surface phenotype and con- 
figuration of the immunoglobulin heavy and light chain loci of 
these cells were determined 3 wk after culture initiation. Consis- 
tent with previously published reports, the cultures contained up 
to  106  cells per 6-cm  2 well and were reproducibly greater than 
85% B220 + (see Fig. 1 A). The cells were heterogeneous with re- 
spect to their expression of the CD43, were BP-1  and expressed 
the  same relative levels of HSA (Fig.  1 A).  11%  of the B220 + 
population  expressed surface  I  x  chain,  a  finding which  is  sup- 
ported by the presence of D-J and V-D-J rearrangements on the 
heavy chain loci as assessed by genomic PCR  (data not shown). 
Light chain rearrangements on the t¢ loci were also detected (data 
not shown). Cells in the cultures were dependent on stromal cell 
contact for survival and displayed a 10-fold expansion in absolute 
cell number in the presence of $17  and IL-7, but failed to form 
colonies in the methylcellulose assay (data not shown). Taken to- 
gether, these cells most closely parallel  those found in Fraction B 
1640  HSA-induced Apoptosis of adult  bone  marrow  (B220+CD43+HSA+BP-1)  as described 
by  Hardy  et  al.  (4),  or in  the  pre-B  I  population  described  by 
P,  olink  and  Melchers  (19).  This  would be  consistent  with  the 
findings that the inhibition of IL-7 activity in vivo (20,  21)  and 
the generation of IL-7-deficient mice (22)  arrests B  cell develop- 
ment at the Fraction B stage.  Our observation that Fraction B  cells 
display heavy and light chain gene rearrangements is supported by 
the findings of others (23). 
To assess the effects ofanti-HSA antibodies on the survival and 
growth  of cells derived from these cultures,  the appropriate  pri- 
mary antibodies  and  corresponding controls were added at vari- 
ous concentrations and allowed to bind to  106 target cells for 15 
min in the incubator.  The number of viable cells at various time 
points  after the  addition  of antibodies  was  assessed  by counting 
the number of trypan blue negative cells in the culture.  To con- 
firm the data concerning the cell viability and to assess the expres- 
sion of the B220  antigen,  cells were stained with anti-B220  and 
PI as previously described. All assays were performed in triplicate. 
Proliferation assays were performed by culturing 2  ×  105 pro-B 
cells per well in complete P,.PMI in 96-well round-bottom plates 
(Falcon  3077;  Becton-Dickinson  and  Co.)  for  24  h.  The  cells 
were  pulsed  with  1  txCi/well  [3H]thymidine  (Amersham)  and 
were harvested  16  h  later with an  LKB  1295-001  cell harvester 
(Uppsala,  Sweden).  Proliferation was  assessed  by measuring iso- 
tope incorporation with a LKB 1205 Betaplate liquid scintillation 
counter  (Uppsala,  Sweden).  All  proliferation  assays  were  per- 
formed in quadruplicate. 
Lymphoid Clonogenic Progenitor  Assay.  Bone  marrow  lymphoid 
clonogenic progenitors  were assayed  in methylcellulose cultures 
containing Iscove's Modified Dulbecco's Medium (IMDM) sup- 
plemented with 2 mM t-glutamine, 30% FCS no. 6350,  100 txM 
2-mercaptoethanol,  and  10 ng/ml human  recombinant  IL-7 de- 
rived from the supernatants  of cos cells transfected with the hu- 
man IL-7 gene. Bone marrow (5 ×  104 cells) was plated into 1-ml 
cultures in 35-mm Greiner petri dishes  (Bellco Glass  Inc., Vine- 
land NJ)  and  cultured for 7  d.  Colonies containing greater than 
50  cells were  enumerated  7  d  after  culture  initiation.  The  cells 
which  initiate  methylcellulose  colonies  are  found  exclusively 
within the B220+CD43 + population (M.S. Chappel, unpublished 
observation)  and  most  closely  correspond  to  Fractions  C  and 
C'(4) and the large pre-B II subpopulation  (19). 
The effects of various antibodies on the frequency of lymphoid 
colony  initiation  was  assessed  by  pre-incubating  bone  marrow 
with the appropriate antibody at the indicated concentrations for 
40 min on ice. Secondary antibodies were added where appropri- 
ate. Cells were washed and plated into methylcellulose cultures as 
described. All assays were performed in quadruplicate. 
Myeloid Clonogenic Progenitor  Assay.  Bone  marrow  (2  ×  104 
cells) was assayed for myeloid clonogenic progenitors in 1 ml me- 
thylcellulose cultures containing IMDM supplemented with 30% 
FCS no.  6250,  2  mM r-glutamine,  3  U/ml erythropoietin,  and 
2% spleen cell conditioned medium. Cells were cultured for 14 d 
and colonies were enumerated and scored as being derived from 
erythroid  (BFU-E) or granulocyte-macrophage  (CFU-GM) pro- 
genitors according to established criteria. 
Experiments to analyze the effects of Various antibodies on the 
initiation of myeloid and  erythroid  colony formation were per- 
formed as described for the lymphoid clonogenic progenitor assay. 
IL- 7-Responsive B Cell Precursor Culture.  IL-7-responsive B  cell 
precursors  were  cultured  as  described  by  Griffiths  et  al.  (24). 
Bone marrow cells were cultured at 2  ×  10  (' cells/ml in IMDM 
supplemented with 20% FCS no. 6350,  50 IxM 2-mercaptoetha- 
nol,  10 ng/ml human  recombinant  IL-7,  10  mM sodium bicar- 
bonate,  10 mM Hepes,  100 U/ml penicillin, 100  ~g/ml strepto- 
mycin,  and  2  mM  glutamine  (complete  IMDM).  After 4  d  in 
culture,  the cells were fed with  1 vol of complete  IMDM.  The 
phenotype of these cells is depicted in Fig. 4 A. The cells in the 
culture were reproducibly greater than 95% B220 + and heteroge- 
neous  with respect  to  CD43  expression.  IgM was  expressed  on 
22%  of the B220 + population,  consistent with the presence  of 
V-D-J rearrangements on the heavy chain loci of cells from these 
cultures.  Rearrangements  were  also  found  on  the  K light  chain 
genes.  Although  others  have  reported  lymphoid  colony forma- 
tion by these cells (24),  we have found that the proliferative po- 
tential  of cells from  these  cultures  is  limited,  since  no  colonies 
were evident when the cells were plated into methylcellulose cul- 
tures at plating densities of up to 106 cells per ml (data not shown). 
Taken  together  these  cultures  likely  represent  a  mixture  of 
Fraction  C'  (B220+CD43+HSA++BP-1+),  Fraction  D  (B220 + 
CD43-1gM-)  and Fractions E and F (B220+CD43  IgM  +) (4) or 
large and small pre-B II cells (19).  The effects of anti-HSA anti- 
bodies on these cells were assessed  as previously described for the 
pro-B  lymphocyte  population.  Proliferation  assays  were  per- 
formed  as  previously  described  using  complete  IMDM  rather 
than complete RPMI. 
Anti-CD40-induced  Proliferation of Mature Resting Splenic B  Cells. 
Spleen  cells  from  6-wk-old  (C57BL/6J  ×  C3H)F1  mice  were 
teased into complete P,  PMI. Red blood cells were lysed in 0.165 M 
ammonium chloride, pH 7.4.  T  cells were removed by two suc- 
cessive treatments with a  1:50 dilution of anti-mouse Thy1.2 as- 
cites  (Cedarlane  Laboratory,  Ontario,  Canada),  1:5  dilutions  of 
G.K 1.5 and 3.155 hybridoma supernatants  (anti-mouse CD4 and 
CD8,  respectively; both from the American Type  Culture  Col- 
lection) on ice for 30 min after by complement depletion at 37°C 
for 40 min using a 1:7 dilution of Low-Tox-Rabbit complement 
(Cedarlane  Laboratories,  Ontario,  Canada).  Small, high buoyant 
density B  lymphocytes were then purified on discontinuous  per- 
coil gradients (Pharmacia Fine Chemicals, Uppsala, Sweden). Cells 
from  the  1.085  g/ml/1.079  g/ml  interface  were  harvested  and 
washed  in  complete  RPMI.  Cells purified  in this  manner were 
>95%  B220 +,  >97%  Ig  +,  and  >95%  of these  cells  displayed 
small forward scatter. To assess the effects of anti-HSA antibodies 
on anti-CD40 driven proliferation of resting B  cells, 1 ×  10  s pu- 
rifled cells in complete RPMI  supplemented  with  1%  of hybri- 
doma supernatant  containing murine  IL-4  (generously provided 
by Dr.  Yang Liu,  New York University Medical  Center)  were 
plated  into  round-bottom  96-well  tissue  culture  plates  (Falcon 
3077,  Becton-Dickinson  and  Co.).  Antibodies were added  to  a 
final concentration  of 20  p,g/ml. After 48 h  in culture,  the cells 
were pulsed for 6 h with 1 IxCi/well [3H]thymidine (Amersham) 
and harvested as previously described. 
Preparation of MI~69 Fab Fragments.  M1/69 Fab was prepared as 
described (17). 
Apoptosis 
Flow Cytometrf.  Nuclear  DNA  fragmentation  in  apoptotic 
cells was assessed  by measuring propidium  iodide content of the 
cells as previously described  (24).  Cells  (106  )  were  fixed for 20 
min on ice in cold 75% ethanol.  Cells were then washed in PBS 
and resuspended  in PBS containing 20  txg/ml propidium iodide 
and 5 txg/ml RNase A. After R.NA digestion at 37°C for 30 min, 
the cells were analyzed for DNA content by flow cytometry us- 
ing a FACSort  ® flow cytometer equipped with a doublet discrim- 
ination  module  and  PC  LYSIS  Il  ® software  (Hewlett  Packard 
Co., Palo Alto, CA). 
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Figure  1.  Phenotypic analysis 
of B cells cultured on $17  and 
effect of HSA cross-linking. (A) 
Phenotypic  analysis  of  pro-B 
cells. Pro-B cell cultures were 
greater than 85% B220  +, hetero- 
geneous with respect to  CD43 
expression and failed to  express 
BP-1. (B) Effect of liSA ligation. 
The sustained  exposure of devel- 
oping pro-B cells to M1/69  -+ 
l:<G7 significantly  decreased their 
output from the culture. 
Gel Electrophoresis.  DNA fragmentation was assessed electro- 
phoretically as  previously described  (25). This method precipi- 
tates high molecular weight DNA during the first cell lysis, thus 
only smaller molecular DNA is evident on the gel. Equal num- 
bers  of cells (5  X  106-1  X  107) were harvested  from untreated 
and M1/69-treated cultures  and washed  in PBS  containing 5% 
FCS. They were subsequently lysed for 10 s in 50/*1 of 50 mM 
Tris-HC1,  pH =  7.5, 20 mM EDTA, and 1% NP-40. After cen- 
trifugation,  the supernatauts  were treated again with lysis buffer 
then were brought to 1% SDS and subjected to R,  Nase A (5 /*g/rnl) 
digestion for 2 h at 56°C.  Proteinase  K was then added to a final 
concentration of 2.5  p~g/ml and the  preparations  were  further 
treated for 2 h at 37°C. After the addition of 0.5 vol of 10 M am- 
monium acetate, the DNA was precipitated  with 2.5 vol of etha- 
nol. The pellets were dissolved in DNA loading buffer and the 
fragments were resolved electrophoretically  on 1% agarose gels. 
Statistical Analysis.  Statistical  analysis  was  performed  with 
the Microsoft  Excel  TM  computer software  package.  All data  are 
represented as the means +  standard deviation of n independent 
experiments performed in triplicate.  IL-7-responsive clonogenic 
progenitor assays and proliferation assays were performed in qua- 
druplicate.  For all experiments, P  values  were  assessed using a 
two-tailed student's t test. 
Results 
The  effect  of cross-linking HSA was  evaluated in four 
developmentally distinct populations of murine B lympho- 
cytes.  Bone marrow cultures were  used as  a  source of B 
cells representative of various stages  of early B cell develop- 
ment. The following developmental stages  were  detected 
and assessed  in these  cultures:  (a)  stromal cell-dependent, 
IL-7-independent pro-B cells,  (b) stromal cell-independent, 
IL-7-dependent clonogenic progenitors,  and  (c)  the  non- 
proliferating progeny  of b.  The  most  mature  population 
studied was mature, resting splenic B lymphocytes. 
Anti-HSA Antibodies Induce  Rapid Cell Death  in  Cultured 
Pro-B Lymphocytes.  To assess the effects of HSA modula- 
tion on the development of B  cell precursors from stroma- 
supported, IL-7-deficient cultures, the HSA-specific M1/69 
antibody (IgG2b)  -  secondary antibody (RG7) was added 
to  the  media  at  culture  initiation and  was  maintained at 
subsequent feedings  for  three  weeks.  In  the  presence  of 
M1/69 alone (5 p~g/ml), cell recovery was 44.3 +  10.0% of 
untreated control cultures (n =  4,  P  <0.05)  (Fig.  1 B).  In 
the presence of a secondary antibody, there was a 400-fold 
mean  reduction  to  0.24  _+  0.11%  of control,  suggesting 
that  the  extent of HSA  cross-linking is  quantitatively re- 
lated to the diminished survival and/or proliferation of the 
cells.  As  previously reported  by  others  (26),  the  yield of 
precursors in the presence of an isotyped matched IgG2b 
anti-LFA-1  antibody  (5  ~g/ml),  either  alone  or  in  the 
presence of cross-linker (2.5  Dg/ml), was indistinguishable 
from that of the untreated cultures, despite that its level of 
surface expression is comparable with that of liSA (data not 
shown). An irrelevant IgG2b antibody (anti-Ly49A) simi- 
larly had no effect on the yield of precursors (Fig. 1 /3) and 
similar results were reproducibly obtained in the presence 
of heat-inactivated FCS (data not shown) ruling out signif- 
icant effects mediated by the Fc'y receptor and/or comple- 
ment activation. 
We next sought to  determine whether M1/69  exerted 
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Figure 2.  Target cells, stromal cell-dependence, dose response and ki- 
netic analysis of M1/69-mediated  loss of pro-B cells. (A) Target cells of 
the  M1/69  antibody. The  direct cellular targets of HSA cross-linking 
were found to be cells derived from the culture at three weeks after cul- 
ture initiation (pro-B cells). (B) Stromal cell and cytokine independence 
of and requirement of crosslinking for HSA-mediated cell loss. (C) Ki- 
netic analysis  of cell loss. A 50% loss of cells relative to untreated cells was 
observed within  5 h.  (D) Dose-response analysis of HSA-mediated cell 
loss. Half maximal recovery of viable cells relative to control was achieved 
at an M1/69 concentration of 5 Izg/ml. 
its negative  effects  on  the  culture-initiating cell, which  is 
thought to be Thy-ll°Lin-Fall-3  -  (27, 28), or whether the 
targets of the antibody were the more mature B220 + B  cell 
precursors.  Total bone  marrow  cells were  incubated with 
M1/69  (5 ~zg/ml) +  secondary antibody (2.5 Dg/ml) for 1 h 
on  ice  and  washed  extensively before plating on  the  $17 
stromal cell layer. The cultures remained free of M1/69  at 
all subsequent time points. This single exposure of the cells 
to  M1/69  before  culture  initiation failed to  diminish  the 
yield of cells at culture maturity (data not shown).  In con- 
trast, B220 + cells derived from 3-wk-old cultures displayed 
exquisite sensitivity to M1/69-mediated cell death (Fig. 2 A). 
Cell number  was  reduced  to  38.79  +  5.30%  of control 
after a  24-h  exposure to the antibody (5  btg/ml), and was 
further diminished to 1.18  +  1.10% of control in the presence 
of a secondary antibody (2.5 Dg/ml)  (n =  4, P  <0.05). Ex- 
tensive washing of the stroma after a 24-h exposure to M1/ 
69  +  P,.G7  allowed the  cultures to completely recover to 
numbers comparable to untreated cultures (data not shown), 
suggesting the presence of a more primitive, M1/69-insen- 
sitive cell. 
To assess whether the effects of the antibody were inde- 
pendent ofstromat cell contact and stromal cell-derived cy- 
tokines, cells were cultured at 106 cells/well in stromal cell- 
free cultures for 24 h  with M1/69  (5 btg/ml)  +  secondary 
antibody (2.5  ~g/ml). M1/69  reduced the number of via- 
ble cells in the culture to an average of 44.39  +  2.08%  of 
control, with a further reduction to 11.31  +  1.08% of con- 
trol in the presence of secondary antibody (Fig. 2  B)  (n  = 
4,  P  <0.05).  Furthermore, M1/69  +  cross-linker similarly 
inhibited [3H]thymidine incorporation in a suspension cul- 
ture  over a  24-h  period (Fig. 2  B).  This effect is epitope- 
independent,  since  the  HSA-specific 20C9  antibody  also 
reduced the number of viable cells in the culture to 55.83  + 
5.81% of control. Furthermore, this effect is dependent on 
the  physical  cross-linking of cell  surface  HSA,  since  the 
monovalent M1/69  Fab  fragment  (5  b~g/ml)  failed to  di- 
minish the number of B  cell precursors over the duration of 
the  experiment.  Similarly,  isotyped  matched  anti-LFA-1 
and anti-VLA-4 controls had no effect on the yield of B  cell 
progenitors.  The  inability of anti-VLA-4 to  diminish the 
yield of cells in the absence ofstromal cells (compare Fig. 1 B 
with 2  B) highlights its critical role in stromal cell adhesion 
processes as  reported by  others  (26)  and  suggests that  the 
mechanistic basis for the M169-mediated loss of precursors 
observed in  the  presence  of stromal  cells is  distinct from 
that  of anti-VLA-4.  Finally,  the  cross-linking of M1/69 
was  also  found  to  decrease  the  number  of Balb/c  B  cell 
precursors derived from similar culture conditions, indicat- 
ing that  the  effects of HSA modulation  were  strain-inde- 
pendent (data not shown). 
M1/69  exerts its effects  over a  very short  time  course, 
since there was a 50% relative loss of viable cells within 5 h 
after the addition ofM1/69  alone (5 t~g/ml) to stroma-free 
suspension  cultures  (n  =  2)  (Fig.  2  C).  Under  the  same 
conditions, the relative loss of viable cells was dose-depen- 
dent over a two log concentration range ofM1/69 in a 24-h 
experiment,  achieving  a  50%  relative  reduction  in  the 
number of viable cells at a concentration of 5  I.tg/ml (n =  2) 
(Fig. 2 D). 
We next wished to determine whether M1/69  inhibited 
the proliferation of B  cell precursors, or whether it directly 
induced cell death.  The  propidium iodide staining profile 
of cells derived from a representative dose response experi- 
ment  (Fig. 3  A)  revealed that  untreated  cultures consisted 
of 60%  viable cells, whereas  in  the  presence  of 5  btg/ml 
M1/69  reduced viability to 25% of control. Culture viabil- 
ity was further reduced to 6% of control in the presence of 
20  btg/ml M1/69.  Consistent with the finding of extensive 
cell death, M1/69-treated  cultures show a  quantitative in- 
crease in DNA  fragmentation with time, as measured by a 
sub-diploid quantity  of DNA  in  propidium  iodide-stained 
nuclei  (Fig.  3  B).  Apoptotic  cell  death  was  further  con- 
firmed electrophoretically by the presence of the character- 
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Figure  3.  Mechanism  of HSA-mediated cell death 
in pro-B cells. (A) Representative propidium iodide 
staining of pro-B cells treated with M1/69 in dose 
response studies (Fig. 2 D) suggested that the ligation 
of HSA induced cell death. (B). DNA content of 
M1/69-treated cells. The incidence of apoptosis (A) 
increased significantly  with time after treatment with 
M1/69.  (C)  Nuclear DNA  fragmentation within 
M1/69-treated cells. DNA was extracted from equal 
numbers of cells either untreated or treated for 4 h 
with M1/69  (5  I.tg/ml) +  RG7  (2.5 I.tg/ml). Un- 
treated cells displayed a small amount of apoptosis, 
whereas considerable DNA fragmentation  was  evi- 
dent in cells treated with M1/69. 
istic pattern of DNA fragmentation obtained from genornic 
DNA prepared from M1/69-treated cells after 4 h in culture 
(Fig. 3  C). Collectively, these data demonstrate that the en- 
gagement  of HSA  rapidly induces  apoptotic  cell  death  in 
early B  cell precursors in a dose-dependent manner. 
HSA  Cross-linking Prohibits Lymphoid Colony Initiation by 
IL-7-Responsive Clonogenic  Progenitors.  To assess the effects 
of cross-linking HSA on more mature lymphoid clonogenic 
progenitors, adult bone marrow cells (3 ×  105 cells/ml) were 
incubated with 5 ~g/rnl M1/69 +  2.5 btg/ml secondary anti- 
body for  1 h  on ice and were  assayed for IL-7-responsive 
clonogenic progenitors in methylcellulose cultures. M1/69 
reduced the frequency of clonogenic progenitors from 6.02 × 
10 -4  --  4.41  ×  10 -s  to  2.21  X  10 -4  +  9.80  X  10 -5, 
whereas  the  presence  of secondary  antibody further  re- 
duced colony formation to  1.53  X  10  s +  0.8  X  10  s or 
3%  of  control  (n  =  3)  (data  not  shown).  All  isotype- 
matched controls and the monovalent M1/69 Fab fragment 
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failed to diminish the frequency of colony formation. Dose 
response  studies  revealed  that  half maximal inhibition of 
colony formation occurs at an M1/69 concentration of 1.0 
I*g/ml (n  =  2)  and that 20C9  and J11/d  similarly inhibit 
lymphoid colony initiation in a  dose-dependent manner, 
indicating that the inhibitory effect of HSA engagement is 
epitope-independent  (data  not  shown).  Taken  together, 
these data demonstrate that the specific modulation of liSA 
on  lymphoid clonogenic progenitors  negatively regulates 
their expansion and that this effect is dependent and pro- 
portional to the extent of cell surface HSA cross-linking. 
The addition oflL-7 at concentrations of up to 100 ng/ml 
in the  methylcellulose cultures failed  to  rescue  lymphoid 
colony formation,  suggesting that  if the  cross-linking of 
HSA negatively regulates cytokine responsiveness, this ef- 
fect cannot be reversed with increased levels of IL-7. 
The Engagement of liSA Induces Cell Death in the Progeny 
oflL-7-Responsive ClonogenicProgenitors.  To  assess the  ef- "~ '"!"  "  i 
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Figure  4.  Phenotypic  analysis of pre-B 
cells and effect of HSA ligation. (A) Pheno- 
typic analysis of pre-B  cells. (B) Effect of 
HSA ligation. The ligation of HSA on pre- 
B cells significantly decreased their survival 
and proliferation (C). (D) Kinetic analysis  of 
cell loss. A 50% loss of cells relative to un- 
treated cells was observed within 2.5 h. (E) 
Dose-response  analysis of  HSA-mediated 
cell loss. Half maximal recovery of viable 
cells relative to control was achieved at an 
M1/69  concentration of 0.30 p~g/ml. 
fects of the M1/69 antibody on the progeny of IL-7-respon- 
sive clonogenic progenitors, bone marrow was cultured in 
IL-7  for  5  d  as  previously  described  (24)  and  cells were 
then  treated  with  anti-HSA antibodies.  The  mean  viable 
cell  recovery  from  M1/69-treated  cultures  was  1.93  + 
0.83%  of control after 24  h  (n  =  3,  P  <0.05)  (Fig. 4  B). 
The effects of HSA ligation were epitope independent and 
dependent on the physical cross-linking of the antigen (Fig. 
4  B).  All results  were  confirmed  in  a  proliferation  assay 
(Fig. 4  C). M1/69  exerts its effects rapidly, since there is a 
50%  loss of cells within  2.5  h  (n  =  2)  (Fig. 4  D).  This is 
twice as fast as that found for IL-7 unresponsive precursors, 
which experience the same reduction within 5  h.  Consis- 
tent with  the  enhanced  sensitivity of this  cell population, 
half maximal  inhibition  of cell  recovery  occurred  at  an 
M1/69  concentration  of 0.30  btg/ml  (n  =  2)  (Fig.  4  E). 
This suggests that these cells are approximately threefold more 
sensitive to HSA modulation than are IL-7-responsive clo- 
nogenic  progenitors  and  are  16-fold  more  sensitive  than 
pro-B cells grown on $17 in the absence oflL-7 (Fig. 2 D). 
Fig. 5 A  demonstrates that there is a dramatic, dose-depen- 
dent loss  of viable cells in M1/69-treated  cultures,  which 
was accompanied by extensive DNA  fragmentation which 
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increased over time following exposure to M1/69  (Fig. 5 
B).  The  presence  of apoptotic  cell  death  was  confirmed 
qualitatively by  agarose  gel  electrophoresis  of DNA  ob- 
tained  from  control  and  M1/69-treated  cells  (Fig.  5  C). 
Taken together, these data suggest that the engagement of 
HSA on IL-7-expanded B  cell precursors negatively regu- 
lates these cells by inducing rapid apoptotic cell death. 
M1/69  Induces Apoptotic  Cell Death  Within the Bone Mar- 
row Compartment  in a Lymphoid-specific Manner.  M1/69,  in the 
presence and absence of secondary antibody had no  effect 
on  the frequency of GEMM,  G/M,  and BFU-E progeni- 
tors (three independent experiments in quadruplicate), de- 
spite their expression of liSA (16,  29,  30),  suggesting that 
the  direct  targets  of HSA-mediated cell  death  are  B  cell 
precursors (data not shown). 
HSA  Cross-linking Inhibits the Anti-CD40-induced  Prolifer- 
ation of Mature Resting Splenic B  Cells.  To  determine  if ma- 
ture resting B  cells, which also express HSA, are susceptible 
to  HSA-mediated apoptosis, splenic B  cells were  purified, 
density fractionated and  cultured in  the  presence  and  ab- 
sence of the M1/69  +  secondary antibody for 6  h.  Apop- 
tosis, as assessed by flow cytometry and DNA electrophore- 
sis,  was  not  detected  in  either  resting  B  cells,  or  cells o 
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Figure  5.  Mechanism  of HSA-mediated 
cell death in pre-B cells. (A) Representative 
propidium  iodide  staining  of  pre-B  cells 
treated  with M1/69.  (B)  DNA  content  of 
M1/69-treated  cells.  (C)  Nuclear  DNA 
fragmentation  within  M1/69-treated  cells. 
DNA  was extracted from equal numbers of 
untreated and treated  cells. DNA  fragmen- 
tation  consistent with  apoptosis was  found 
in M1/69-treated cells. 
activated for 48 h  with anti-CD40,  IL-4 anti-CD40  +  IL-4, 
or LPS (data not shown). Nevertheless,  the cross-linking of 
HSA on mature resting B  cells inhibited  their proliferative 
response to anti-CD40 by 50%  (n  =  3,  P  <0.05)  (Fig.  6). 
This was further exacerbated by the presence of IL-4, since 
cells  stimulated  with  CD40  +  IL-4  experienced  an  80% 
mean  reduction  in  thymidine  incorporation  as  result  of 
HSA  cross-linking.  In  contrast  with  its  effects  on  anti- 
CD40-induced  proliferation,  HSA  cross-linking  had  no 
effect  on  LPS-mediated  proliferation  (data  not  shown). 
Taken  together,  this  data suggests  that HSA can provide a 
signal which suppresses the activation of mature B  cells by a 
mechanism which is distinct from HSA-mediated apoptosis 
of early B  cell precursors. 
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Discussion 
Our findings have revealed two novel properties of HSA 
which may shed light on its potential roles in B  cell devel- 
opment and activation.  Cross-linking HSA on three func- 
tionally distinguishable precursor populations was found to 
significantly  diminish  their  survival  in  a  dose-dependent 
manner through the induction of apoptosis, and also mark- 
edly reduced the anti-CD40 proliferative  responses  of ma- 
ture, resting splenic B  cells.  Taken together, these data sup- 
port  a  role  for  HSA  in  the  negative  regulation  of the 
survival of early B  cell precursors  and the proliferative  re- 
sponse of mature, peripheral B  cells. 
Cultured B  cell  precursors displayed increasing sensitivity 
to HSA-mediated cell death with developmental maturity, 1.50' 
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Figure  6.  Effect of HSA liga- 
tion on the proliferative response 
of mature B cells.  The ligation of 
HSA  significantly  impaired  the 
ability  of the  cells  to  proliferate 
in response to anti-CD40  +  IL-4. 
despite having the same relative levels of surface HSA ex- 
pression.  This finding  could be associated with  the  stage- 
specific regulation  of molecules known  to be involved in 
regulating  cell  death,  such  as  bcl-2  (31),  bcl-x  (32),  bax 
(33),  c-myc (34),  p53 (35), as well as tyrosine kinases which 
have been shown to be activated in B  cell precursors un- 
dergoing apoptosis (36).  Indeed the progressive down reg- 
ulation  of bcl-2 in  Fraction  C  and D  populations  (4,  24) 
support this hypothesis.  Conversely, since Fraction C  cells 
are  rapidly  proliferating  in  response  to  IL-7  (4,  19),  the 
higher  frequency  of cells  in  S and  G2 phases of the  cell 
cycle  could  similarly  render  them  more  susceptible  to 
M1/69-mediated  cell  death.  The  enhanced  sensitivity  of 
the  IL-7 responsive populations could also point to a role 
for HSA in the conversion of a proliferative signal into an 
inhibitory one, a model which has been proposed by others 
who  have  shown  that  the  induction  of apoptosis  by the 
cross-linking of CD38 on human B cell precursors (37) and 
CD43 on human bone marrow progenitors (38) is similarly 
dependent on the presence of and responsiveness to cyto- 
kines.  Alternatively,  developmentally  regulated,  differen- 
tial glycosylation of HSA could account for stage-specific 
lateral  interactions  with  molecules which  participate with 
HSA in the induction of apoptosis. 
The  ability  of M1/69  to  induce  apoptosis  thus  far ap- 
pears to be restricted to the lymphoid compartment, since 
colony initiation by myeloid and erythroid progenitors was 
unaffected by the antibody, despite their expression of liSA 
(16,  29,  30).  Interestingly, the ligation of HSA on all mu- 
rine B  cell lines tested thus far, including several Abelson- 
transformed B cell lines, WEHI 231, Bal 17, and A20 failed 
to inhibit proliferation or induce apoptosis (data not shown). 
Two caveats argue against the simple model of HSA as 
an adhesion  molecule.  HSA expression increases as B  cell 
precursors  become  less  stromal  cell-dependent  (4)  with 
stroma-independent precursors being the most sensitive to 
HSA-mediated apoptosis. Second, M1/69 Fab failed to in- 
duce cell death, suggesting that the steric blocking of inter- 
cellular interactions is not responsible for our observations. 
An alternative model is that HSA transduces signals  either 
directly,  or by virtue of its association with  a complex of 
molecules, whose activity may also  be regulated by HSA. 
The  findings  that  M1/69  directly  induces  apoptosis  in  a 
cross-linking-dependent  manner,  that  the  cross-linking of 
HSA with mAb 79 induces a Ca  2+ flux on its own (12) and 
when it is complexed with other molecules (15),  and that 
other GPI-linked proteins such as Thy-1  (39),  decay accel- 
erating factor (40),  CD59 (41),  and the human homologue 
of HSA, CD24  (41),  are found in close physical association 
with src tyrosine kinases also strengthens this hypothesis. 
This work demonstrates that HSA cross-linking has sig- 
nificant and differential effects at several stages of B cell de- 
velopment. In a physiological context, the ligation of HSA 
in  the  bone  marrow  may participate  in  mechanisms  that 
regulate  the  production  of B  cell precursors.  Indeed,  the 
cells  which  display the greatest sensitivity to HSA ligation 
in vitro are coincident with those lost in the developmental 
transition from large pre-B cells  (Fractions C-C') to small 
pre-B cells  (Fraction D)  observed during B  cell genesis in 
vivo (42,  43),  thus,  HSA may be involved in the elimina- 
tion of precursors with  aberrant or non-productive heavy 
and light chain gene rearrangements, or cells which display 
self specificity. Alternatively, HSA may be involved in the 
elimination of cells  which  remain inappropriately adhered 
to the stroma, hence, the ligation of HSA by continued at- 
tachment to the bone marrow matrix would rapidly induce 
cell death in cells which have acquired IL-7 responsiveness 
and enhanced sensitivity to HSA-mediated cell death. 
The  ligation  of HSA  on  mature  B  cells  may serve  to 
limit the activation and expansion of non-specific bystander 
B  cells  in  the  propagation of the  immune  response.  This 
model has similarly been proposed to explain the enhanced 
sensitivity of anti-CD40-activated mouse  (44)  and human 
(45,  46) B cells to Fas-mediated cell death in the absence of 
antigen receptor cross-linking in vitro. Intriguingly, a small 
population  of cells  appear to be resistant  to  the  effects of 
HSA cross-linking, since thymidine incorporation of anti- 
CD40-activated  cells  remains  unchanged  at  M1/69  con- 
centrations  of up  to  100  btg/ml  (data  not  shown).  These 
cells may represent memory B cell precursors, which express 
very low levels of the HSA antigen (6, 7). Since relative levels 
of HSA expression on peripheral B lymphocytes distinguishes 
primary from memory precursors, signals transduced through 
HSA during early development may participate in the bi- 
furcation of B  cell lineages and account for the functional 
differences observed between B cell populations expressing 
relatively different levels of surface HSA (6, 7). 
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